Physician profile
Leslie E Schwindel
NPI 1720215254
$5,717.12
in general payments reported to CMS, 2019-2025
10 companies · $262 in 2025
The $262 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,275 · 2020: $135 · 2021: $311 · 2022: $3,419 · 2023: $54.85 · 2024: $260 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $576.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,354.81 | 2021-2025 | Q-Fix, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Stryker Corporation | $1,712.24 | 2019-2025 | Mako, Blueprint Patient Specific Instrumentation, T2 |
| Zimmer Biomet Holdings, INC. | $1,352.17 | 2019-2022 | |
| Wright Medical Technology, INC. | $85.65 | 2020 | |
| Horizon Therapeutics Plc | $80.82 | 2022 | |
| Blue Surgical LLC | $53.91 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $26.02 | 2022 | |
| Fidia Pharma USA INC. | $17.86 | 2025 | Hymhyn |
| Kci USA, INC. | $17.71 | 2021 | |
| Polynovo North America LLC | $15.93 | 2025 | Novosorb Btm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Schwindel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.